Radiofrequency in Female Pattern Hair Loss

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-25

Study Completion Date

2022-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pattern hair loss, also called androgenetic alopecia (AGA) is considered the most common cause of hair loss in both males and females affecting approximately 85% of males and 50% of females over 50 years of age.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fractional Laser Versus Radiofrequency in Androgenetic Alopecia

NCT05435625

Androgenic Alopecia

UNKNOWN NA

Point-of-Care Adipose-derived Cells for Hair Growth

NCT02729415

Androgenetic Alopecia

COMPLETED NA

Efficacy of Combined Microneedling With Methotrexate in Treatment of Alopecia Areata

NCT05485571

Alopecia Areata

UNKNOWN NA

Fractional Photothermolysis for Hair Follicle Induction

NCT03382184

Alopecia

ACTIVE_NOT_RECRUITING EARLY_PHASE1

Fractional Non-ablative Laser for the Treatment of Hair Loss

NCT04953416

Alopecia

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

RF (Radiofrequency) based devices have also been shown to be successful in promoting hair growth, thought to occur through the induction of growth factors in the papillary dermis. Studying the effect of fractional needling radiofrequency in the treatment of female pattern hair loss will pave the way for more treatment options for this common disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Female Pattern Baldness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fractional microneedling radiofrequency

Device

Group Type ACTIVE_COMPARATOR

Vivacy

Intervention Type OTHER

Vivacy and minoxidil

Fractional microneedling radiofrequency followed by minoxidil application

Device and drug

Group Type ACTIVE_COMPARATOR

Vivacy

Intervention Type OTHER

Vivacy and minoxidil

Minoxidil

Topical drug

Group Type ACTIVE_COMPARATOR

Vivacy

Intervention Type OTHER

Vivacy and minoxidil

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vivacy

Vivacy and minoxidil

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with female pattern hair loss

Exclusion Criteria

* \- Pregnancy and lactation.
* Bleeding tendency.
* Cases who received treatment (systemic or topical) in the last 3 months before treatment.
* Scarring alopecia.
* Other associated causes of alopecia

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No